About Dhruvi Pharma Private Limited
Data last updated:
Dhruvi Pharma Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Keimed Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 16 July 2001.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24231TS2001PTC171830. Its GSTIN is 08AABCD3983H1ZI (Rajasthan). The company held 3 GST registrations, all of them active.
The company had an authorised share capital of ₹9.65 Cr and a paid-up capital of ₹1.56 Cr. It was led by directors including Rupesh Hemendra Shah (Managing Director) and Deeptiben Rupeshbhai Shah.
Its last annual general meeting (AGM) was held on 01 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at Hyderabad, Telangana.
As per the financials filed for FY 2023, the company reported a revenue of ₹471.76 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹3.11 Cr (net margin 0.7%) and EBITDA of ₹11.56 Cr (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 19% over five years.
The company had about 375 employees on its provident fund (EPFO) records before it was dissolved. Its group structure included 4 subsidiaries.
The company was associated with 1 brand: Dhruvi Pharma. As per MCA filings, the company had satisfied charges of ₹57.75 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company. The company has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹9.2 Cr; the latest was in April 2019. Its 10 peer companies in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution) are compared by revenue, 5 larger and 5 smaller; the largest is Agfa Healthcare India Private Limited with revenue of ₹492.84 Cr.
The last known website on record is dhruvipharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressShe No – 2 7 – 2 – 1740, Fire Station Main Road Sanath Nagar, Hyderabad, Telangana, India – 500018
- IndustryHealthcare, Medical Equipment Retail & Distribution
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Dhruvi Pharma Private Limited
The main business activity of Dhruvi Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Dhruvi Pharma Private Limited FY 2023 filings available
Dhruvi Pharma Private Limited reported revenue of ₹471.76 Cr (up 22% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Dhruvi Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 22% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dhruvi Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹471.76 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹11.56 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.11 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dhruvi Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dhruvi Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Dhruvi Pharma Private Limited
Dhruvi Pharma Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Agfa Healthcare India Private Limited | ₹492.84 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Thane, Maharashtra, India |
| M.S Life Drug House Private Limited | ₹488.75 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Kolkata, West Bengal, India |
| Nipro Medical (India) Private Limited | ₹486.02 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Chennai, Tamil Nadu, India |
| Royal Canin India Private Limited | ₹473.84 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Mumbai, Maharashtra, India |
| Aadishwar Excipients Private Limited | ₹472.49 Cr (FY 2025) | •••• | •••• | 42.0% | •••• | Chennai, Tamil Nadu, India |
| Dhruvi Pharma Private Limited this company | ₹471.76 Cr (FY 2023) | •••• | •••• | 22.0% | •••• | Hyderabad, Telangana, India |
| M.P.C. Pharma Private Limited | ₹455.3 Cr (FY 2024) | •••• | •••• | 16.0% | •••• | Chennai, Tamil Nadu, India |
| Akumentis Healthcare Limited | ₹449.08 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Delhi, India |
| Roche Diabetes Care India Private Limited | ₹445.51 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Mumbai, Maharashtra, India |
| Rajsons Pharma Private Limited | ₹439.52 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Bangalore, Karnataka, India |
| Ritemed Pharma Retail Private Limited | ₹434.14 Cr (FY 2016) | •••• | •••• | 32.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Dhruvi Pharma by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Dhruvi Pharma Private Limited
Dhruvi Pharma Private Limited is audited by Hemanshu Shah & Co. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Hemanshu Shah & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Dhruvi Pharma Private Limited
Dhruvi Pharma has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arvind Kumar Venkat | Nominee Director | 09 Mar 2015 | 11 Years 7 Months | As last reported |
| Rupesh Hemendra Shah Also directs: Relicorp Logistics LLP, Meditree Lifecare LLP, Yashvi Distribution Services Private Limited and 5 more | Managing Director | 16 Jul 2001 | 25 Years 2 Months | As last reported |
| Yashwant Singh | Nominee Director | 03 Jul 2018 | 8 Years 3 Months | As last reported |
| Deeptiben Rupeshbhai Shah Also directs: Relicorp Logistics LLP, Yashvi Distribution Services Private Limited, Yashvi Pharma Private Limited and 4 more | Director | 16 Jul 2001 | 25 Years 2 Months | As last reported |
Ownership and Shareholding of Dhruvi Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dhruvi Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Sep 2016 | Hdfc Bank Limited | ₹1 Cr | Satisfied |
| 26 Feb 2015 | Hdfc Bank Limited | ₹50 Cr | Satisfied |
| 29 Sep 2011 | Yes Bank Limited | ₹5.25 Cr | Satisfied |
| 20 Nov 2007 | 3I Infotech Trusteeship Services Limited | ₹1.5 Cr | Satisfied |
Total charge records: 4 View all charges
Deals & Funding of Dhruvi Pharma Private Limited
Dhruvi Pharma Private Limited has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹9.2 Cr; the latest was in April 2019.
Deals on record (4 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2016 | Funding round | ₹1.3 Cr | Investors: Keimed Private Limited , 2 individuals |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: Keimed Private Limited Seller: 4 individuals |
| Nov 2013 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: an individual |
| May 2010 | Funding round | ₹25 Lakh | Investors: 2 individuals |
Full deal history
All 5 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Dhruvi Pharma Private Limited
Dhruvi Pharma Private Limited has 2 court cases on record: 2 filed by Dhruvi Pharma. All cases are disposed. Status as checked between 02 Oct 2026 and 05 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| Supreme Court | 1 | 0 | 0 |
| High courts | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Gujarat | Court case (TAXAP) | Filed by the company against Joint Commissioner of Income Tax (Osd) | Disposed |
| Supreme Court | Appeal | Filed by the company against Joint Commissioner of Income Tax(Osd) | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Dhruvi Pharma Private Limited
Dhruvi Pharma operates one associated brand: Dhruvi Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides ethical distribution of pharmaceutical products and supply chain management services. | dhruvipharma.com |
Employees and EPFO Compliance at Dhruvi Pharma Private Limited
Dhruvi Pharma Private Limited has a workforce of 375 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Dhruvi Pharma Private Limited
Dhruvi Pharma has 4 subsidiary companies. This group structure data is as of FY 2022. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Yashvi Pharma Private Limited | U51909GJ2003PTC042344 | Locked |
| Atc Pharma Private Limited | U51909GJ2019PTC106215 | Locked |
| Dhruvi Healthcare Private Limited | U51909GJ2022PTC129886 | Locked |
| Anila Medical Private Limited | U51909MP2020PTC051475 | Locked |
Showing major subsidiaries. Total: 4.
CIN History of Dhruvi Pharma Private Limited
Dhruvi Pharma has one previous CIN (Corporate Identification Number): U24231GJ2001PTC039783. The current CIN is U24231TS2001PTC171830, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231TS2001PTC171830 | Current |
| U24231GJ2001PTC039783 | Previous |
Recent Activity on Dhruvi Pharma Private Limited
Dhruvi Pharma Private Limited has 7 board changes on record since 2001: 4 appointments and 3 cessations. The latest: Arvind Kumar Venkat ceased to be Director on 26 Jun 2019.
9 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Dhruvi Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dhruvi Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dhruvi Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dhruvi Pharma Private Limited
Dhruvi Pharma has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AABCD3983H1ZI | Rajasthan | Active | 01 Jul 2017 |
| 23AABCD3983H1ZQ | Madhya Pradesh | Active | 01 Jul 2017 |
| 24AABCD3983H1ZO | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dhruvi Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dhruvi Pharma Private Limited
Dhruvi Pharma has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Dhruvi Pharma was a private limited company based in Hyderabad, Telangana, India. The company worked in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 16 July 2001 and is registered under CIN U24231TS2001PTC171830. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Dhruvi Pharma was incorporated on 16 July 2001. It is registered with the Registrar of Companies, Hyderabad.
Dhruvi Pharma had 4 directors:
- Rupesh Hemendra Shah - Managing Director
- Arvind Kumar Venkat - Nominee Director
- Yashwant Singh - Nominee Director
- Deeptiben Rupeshbhai Shah - Director
The CIN (Corporate Identification Number) of Dhruvi Pharma is U24231TS2001PTC171830. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Dhruvi Pharma is at She No – 2 7 – 2 – 1740, Fire Station Main Road Sanath Nagar, Hyderabad, Telangana, India – 500018.
Dhruvi Pharma can be reached through the website dhruvipharma.com. Its registered office is in Hyderabad, Telangana, India.
Dhruvi Pharma reported revenue of ₹471.76 Cr for FY 2023 (up 22% YoY).
Dhruvi Pharma has an authorised share capital of ₹9.65 Cr and a paid-up capital of ₹1.56 Cr.
Dhruvi Pharma reported a net profit of ₹3.11 Cr (net margin 0.7%) and EBITDA of ₹11.56 Cr (EBITDA margin 2.4%) for FY 2023, as per its filed financial statements.
The GSTIN of Dhruvi Pharma is 08AABCD3983H1ZI, registered in Rajasthan. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 23AABCD3983H1ZQ (Madhya Pradesh), 24AABCD3983H1ZO (Gujarat).